Testing AI vs. tumor boards for cancer treatment advice
Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a synthetic case (not a real patient) in one of these cancers: breast, lung, urological, digestive, or gynecological.
- The case must include complete details like cancer stage, biomarkers, your ability to perform daily activities, and other health conditions.
- The case must have a clear, answerable question about which treatment to use, based on current medical guidelines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (AI) helper that assists doctors in managing thyroid cancer. It aims to see if the tool can improve care for patients like you.
This trial uses an artificial intelligence model to improve the accuracy of diagnosing early-stage breast cancer. The AI analyzes breast mass pathology results to help doctors make better decisions.
This study compares how an artificial intelligence system and a team of cancer doctors recommend treatment for rectal cancer. By understanding how well they agree, researchers hope to improve cancer treatment planning.
This study compares treatment recommendations from a computer system with those from a team of cancer doctors. It may help improve how cancer care decisions are made.
This study is testing how well AI can help with diagnosis and treatment by looking at medical records of patients from four hospitals, specifically those with urological conditions. It's a way to see if AI can improve care without needing any new tests or visits.
This trial tests whether artificial intelligence can help doctors plan better treatment for non-small cell lung cancer (NSCLC). A team of specialists will use AI tools alongside their usual approach to see if it improves care and safety.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.